SPI Pharma, Inc.
SPI Pharma is a global leader in pharmaceutical formulation innovation, providing solutions such as high-performance excipients, taste-masking technology, and vaccine adjuvants. Their mission is to engineer functional materials that solve formulation problems, enable differentiation, and accelerate time to market for pharmaceutical clients worldwide. They serve over 55 countries with a focus on patient-friendly dosage forms, including tablets, softgels, and vaccines.
Industries
Nr. of Employees
large (251-1000)
Patents
Highly compactable and durable direct compression excipients and excipient systems
US-11672763-B2
View Details
Highly compactable and durable direct compression excipients and excipient systems
US-11672763-B2
View DetailsProducts
Taste-masked acetaminophen granules (aqueous hydrogel-coated)
Aqueous hydrogel-coated acetaminophen granules formulated to provide a taste barrier, high API loading, solvent-free manufacture, rapid dissolution at gastric pH, and properties suitable for chewables, ODTs, and stick packs.
Aluminum hydroxide gel vaccine adjuvant grades
Range of aluminum hydroxide (pseudo-boehmite) gel grades for antigen adsorption, including high-adsorption grades with finer particle size and tailored pH range for improved protein adsorption.
Saponin-based vaccine adjuvant materials
Saponin-class adjuvant materials added to the adjuvant portfolio to support alternative immune-stimulatory mechanisms in vaccine formulations.
Taste-masked acetaminophen granules (aqueous hydrogel-coated)
Aqueous hydrogel-coated acetaminophen granules formulated to provide a taste barrier, high API loading, solvent-free manufacture, rapid dissolution at gastric pH, and properties suitable for chewables, ODTs, and stick packs.
Aluminum hydroxide gel vaccine adjuvant grades
Range of aluminum hydroxide (pseudo-boehmite) gel grades for antigen adsorption, including high-adsorption grades with finer particle size and tailored pH range for improved protein adsorption.
Saponin-based vaccine adjuvant materials
Saponin-class adjuvant materials added to the adjuvant portfolio to support alternative immune-stimulatory mechanisms in vaccine formulations.
Services
Consultative drug development program providing formulation development, optimization, prototyping, stability testing, analytical method development and validation, regulatory dossier support, and technology transfer to take products from concept to commercialization.
Consultative drug development program providing formulation development, optimization, prototyping, stability testing, analytical method development and validation, regulatory dossier support, and technology transfer to take products from concept to commercialization.
Expertise Areas
- Vaccine adjuvant materials and manufacturing
- Taste-masking and oral formulation development
- Orally disintegrating tablet (ODT) platforms
- Direct-compression excipient development
Key Technologies
- Aqueous coacervation hydrogel coatings for taste-masking
- Micronization and particle-size control
- Aluminum hydroxide (pseudo-boehmite) adjuvant materials
- Saponin-based adjuvant materials
News & Updates
A review of SPI Pharma's achievements and highlights in 2022, including webinars on taste-masking and ODT formulation.
Celebrating 50 years of the Lewes facility and the contributions of Guy Wiggins and his family.
Discussion on SPI Pharma’s innovative taste-masking technology and its support for global product launches.
A review of SPI Pharma's achievements and highlights in 2022, including webinars on taste-masking and ODT formulation.
Celebrating 50 years of the Lewes facility and the contributions of Guy Wiggins and his family.
Discussion on SPI Pharma’s innovative taste-masking technology and its support for global product launches.